OS Therapies

NYSE: OSTX · Real-Time Price · USD
2.06
-0.09 (-4.19%)
At close: Aug 15, 2025, 3:59 PM
2.07
0.24%
After-hours: Aug 15, 2025, 07:31 PM EDT

OS Therapies Balance Sheet Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
5.53M 38.98K 171.48K 80.79K
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
n/a n/a n/a n/a
Receivables
n/a n/a 1.15K 231.07K
Inventory
n/a n/a n/a n/a
Other Current Assets
n/a 751.05K 324.21K n/a
Total Current Assets
5.53M 790.03K 496.83K 312.81K
Property-Plant & Equipment
5.27K 8.05K 12.27K 13.08K
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
5.27K 8.05K 12.27K 13.08K
Total Assets
5.54M 798.08K 509.11K 325.89K
Account Payables
1.66M 2.72M 1.23M 856.52K
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
n/a 14.61M n/a n/a
Other Current Liabilities
2.87M 4.71M 1.46M 1.61M
Total Current Liabilities
4.63M 24.71M 6.15M 3.5M
Long-Term Debt
n/a n/a 10.35M 7.07M
Other Long-Term Liabilities
n/a n/a 1.47M 1.11M
Total Long-Term Liabilities
100K 100K 11.92M 8.28M
Total Liabilities
4.73M 24.81M 18.07M 11.78M
Total Debt
n/a 14.61M 10.35M 7.07M
Common Stock
20.87K 5.34K 9.98K 9.98K
Retained Earnings
-40.4B -29.52M -21.6M -15.22M
Comprehensive Income
n/a n/a n/a n/a
Shareholders Equity
6.05B -24.02M -17.56M -11.45M
Total Investments
5.53B n/a n/a n/a